These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 12585172)
1. [Effect of bushen yanggan recipe on nigrostriatal function in parkinsonian model rats after long-term levodopa treatment]. Cai DF; Chen XQ; Gao Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jan; 22(1):43-6. PubMed ID: 12585172 [TBL] [Abstract][Full Text] [Related]
2. Effects of Combined Bushen Zhichan Recipe and Levodopa in a Rodent Model of Parkinson Disease: Potential Mechanisms. Li W; Gao H; Li W Med Sci Monit; 2020 Jun; 26():e922345. PubMed ID: 32555131 [TBL] [Abstract][Full Text] [Related]
3. [Effects of traditional Chinese herbal medicine on the neurobehavioral manifestations and the activity of dopamine D2 receptor in corpora striatum of rats with levodopa-induced dyskinesias]. Yuan CX; Ye Q; Wang J; Zhang Y; Yuan CG Zhong Xi Yi Jie He Xue Bao; 2008 Oct; 6(10):1024-8. PubMed ID: 18847536 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats. Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078 [TBL] [Abstract][Full Text] [Related]
5. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study. Boulamery A; Simon N; Vidal J; Bruguerolle B Chronobiol Int; 2010 Jan; 27(2):251-64. PubMed ID: 20370468 [TBL] [Abstract][Full Text] [Related]
7. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease. Marin C; Bonastre M; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA Exp Neurol; 2013 Dec; 250():304-12. PubMed ID: 24140562 [TBL] [Abstract][Full Text] [Related]
8. [Effects of yanggan xifeng recipe on changes of neurological behavior of rat of Parkinson's model]. Li W; Cai D; Chen X Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Dec; 20(12):920-2. PubMed ID: 11938865 [TBL] [Abstract][Full Text] [Related]
9. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343 [TBL] [Abstract][Full Text] [Related]
10. Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats. Marin C; Bonastre M; Mengod G; Cortés R; Giralt A; Obeso JA; Schapira AH Neurobiol Dis; 2014 Apr; 64():36-47. PubMed ID: 24370700 [TBL] [Abstract][Full Text] [Related]
11. [Effects of Chinese herbal medicine Tianqi Pingchan Granule on G protein-coupled receptor kinase 6 involved in the prevention of levodopa-induced dyskinesia in rats with Parkinson disease]. Wu N; Song L; Yang XX; Wei JL; Liu ZG Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1018-24. PubMed ID: 22979934 [TBL] [Abstract][Full Text] [Related]
13. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Shin KS; Choi HS; Zhao TT; Suh KH; Kwon IH; Choi SO; Lee MK Arch Pharm Res; 2013 Jun; 36(6):759-67. PubMed ID: 23539311 [TBL] [Abstract][Full Text] [Related]
14. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Thomas J; Wang J; Takubo H; Sheng J; de Jesus S; Bankiewicz KS Exp Neurol; 1994 Apr; 126(2):159-67. PubMed ID: 7925817 [TBL] [Abstract][Full Text] [Related]
15. The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation. Yamamoto T; Uchiyama T; Sakakibara R; Taniguchi J; Kuwabara S Neuroscience; 2014 Feb; 259():43-52. PubMed ID: 24291727 [TBL] [Abstract][Full Text] [Related]
16. A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions. Han B; Jin HJ; Song MY; Wang T; Zhao H Parkinsonism Relat Disord; 2014 Nov; 20(11):1191-5. PubMed ID: 25219971 [TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870 [TBL] [Abstract][Full Text] [Related]
18. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803 [TBL] [Abstract][Full Text] [Related]
19. Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats. Cao F; Sun S; Tong ET J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):151-3. PubMed ID: 12973934 [TBL] [Abstract][Full Text] [Related]
20. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]